DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$8.720-0.250 (-2.787%)

Precio en Tiempo Real

Healthcare
Biotecnología
Francia

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$8.970

Máximo

$9.046

Mínimo

$8.720

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

252.2M

Industria

Biotecnología

País

France

Estadísticas de Negociación

Volumen Promedio

0.44M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.441Actual $8.720Máximo $12.78

Noticias Relacionadas

GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

Ver más
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

Ver más
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of

Ver más
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
GlobeNewswire

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company (the

Ver más
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Analyst Upgrades

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies with a Market Outperform and raises the price target from $15 to $21.

Ver más
JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.